Nautilus Biotechnology, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Net income | -$59.0 | -$70.8 | -$63.7 | -$57.9 | -$50.3 |
| Cash Flow Statement | |||||
| Free cash flow | -$52.0 | -$61.3 | -$54.2 | -$48.1 | -$41.5 |
Shares outstanding 127.3M · Free float 33.1%
Annual filing data through FY ended December 31, 2025; float as of September 13, 2026.